Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1980 1
1981 2
1983 3
1984 1
1985 1
1989 1
1999 1
2000 2
2003 3
2004 2
2005 2
2006 2
2007 4
2008 7
2009 5
2010 5
2011 2
2012 5
2013 5
2014 4
2015 7
2016 4
2017 6
2018 4
2019 4
2020 4
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 22849856

80 results
Results by year
Filters applied: . Clear all
Page 1
Towards the use of non-psychoactive cannabinoids for prostate cancer.
Pacher P. Pacher P. Br J Pharmacol. 2013 Jan;168(1):76-8. doi: 10.1111/j.1476-5381.2012.02121.x. Br J Pharmacol. 2013. PMID: 22849856 Free PMC article.
Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro-apoptotic effects and underlying mechanisms.
De Petrocellis L, Ligresti A, Schiano Moriello A, Iappelli M, Verde R, Stott CG, Cristino L, Orlando P, Di Marzo V. De Petrocellis L, et al. Br J Pharmacol. 2013 Jan;168(1):79-102. doi: 10.1111/j.1476-5381.2012.02027.x. Br J Pharmacol. 2013. PMID: 22594963 Free PMC article.
Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma.
Ligresti A, Moriello AS, Starowicz K, Matias I, Pisanti S, De Petrocellis L, Laezza C, Portella G, Bifulco M, Di Marzo V. Ligresti A, et al. J Pharmacol Exp Ther. 2006 Sep;318(3):1375-87. doi: 10.1124/jpet.106.105247. Epub 2006 May 25. J Pharmacol Exp Ther. 2006. PMID: 16728591
The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids.
McAllister SD, Soroceanu L, Desprez PY. McAllister SD, et al. J Neuroimmune Pharmacol. 2015 Jun;10(2):255-67. doi: 10.1007/s11481-015-9608-y. Epub 2015 Apr 28. J Neuroimmune Pharmacol. 2015. PMID: 25916739 Free PMC article. Review.
A Brief Background on Cannabis: From Plant to Medical Indications.
Klumpers LE, Thacker DL. Klumpers LE, et al. J AOAC Int. 2019 Mar 1;102(2):412-420. doi: 10.5740/jaoacint.18-0208. Epub 2018 Aug 23. J AOAC Int. 2019. PMID: 30139415 Free article. Review.
Plant-derived cannabinoids modulate the activity of transient receptor potential channels of ankyrin type-1 and melastatin type-8.
De Petrocellis L, Vellani V, Schiano-Moriello A, Marini P, Magherini PC, Orlando P, Di Marzo V. De Petrocellis L, et al. J Pharmacol Exp Ther. 2008 Jun;325(3):1007-15. doi: 10.1124/jpet.107.134809. Epub 2008 Mar 19. J Pharmacol Exp Ther. 2008. PMID: 18354058
Effects of cannabinoids Δ(9)-tetrahydrocannabinol, Δ(9)-tetrahydrocannabinolic acid and cannabidiol in MPP+ affected murine mesencephalic cultures.
Moldzio R, Pacher T, Krewenka C, Kranner B, Novak J, Duvigneau JC, Rausch WD. Moldzio R, et al. Phytomedicine. 2012 Jun 15;19(8-9):819-24. doi: 10.1016/j.phymed.2012.04.002. Epub 2012 May 7. Phytomedicine. 2012. PMID: 22571976
Neuroprotective antioxidants from marijuana.
Hampson AJ, Grimaldi M, Lolic M, Wink D, Rosenthal R, Axelrod J. Hampson AJ, et al. Ann N Y Acad Sci. 2000;899:274-82. Ann N Y Acad Sci. 2000. PMID: 10863546 Review.
Phyto-, endo- and synthetic cannabinoids: promising chemotherapeutic agents in the treatment of breast and prostate carcinomas.
Fraguas-Sánchez AI, Fernández-Carballido A, Torres-Suárez AI. Fraguas-Sánchez AI, et al. Expert Opin Investig Drugs. 2016 Nov;25(11):1311-1323. doi: 10.1080/13543784.2016.1236913. Epub 2016 Sep 28. Expert Opin Investig Drugs. 2016. PMID: 27633508 Review.
80 results
Jump to page